Edition:
India

Takeda Pharmaceutical Cancels Bridge Credit Agreement


Friday, 21 Dec 2018 

Dec 21 (Reuters) - Takeda Pharmaceutical Co Ltd <4502.T>::STATEMENT REGARDING BRIDGE CANCELLATION.INTENDS TO FUND CASH CONSIDERATION DUE ON COMPLETION OF PROPOSED ACQUISITION OF SHIRE FROM ITS CASH RESOURCES AND OTHER FINANCING SOURCES.CANCELLED IN FULL REMAINING COMMITMENTS UNDER 364-DAY BRIDGE CREDIT AGREEMENT ENTERED INTO IN CONNECTION WITH THE ACQUISITION ON MAY 8.SOME TECHNICAL AMENDMENTS BEING MADE TO TERM LOAN CREDIT AGREEMENT DATED JUNE 8, SENIOR SHORT-TERM LOAN FACILITY AGREEMENT DATED OCT 26.